1. Home
  2. OPRT vs CBUS Comparison

OPRT vs CBUS Comparison

Compare OPRT & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oportun Financial Corporation

OPRT

Oportun Financial Corporation

HOLD

Current Price

$4.76

Market Cap

199.4M

Sector

Finance

ML Signal

HOLD

Logo Cibus Inc.

CBUS

Cibus Inc.

HOLD

Current Price

$1.59

Market Cap

208.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPRT
CBUS
Founded
2005
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Agricultural Chemicals
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
199.4M
208.7M
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
OPRT
CBUS
Price
$4.76
$1.59
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$7.25
$9.00
AVG Volume (30 Days)
538.8K
663.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
127.18
74.33
EPS
0.53
N/A
Revenue
$956,685,000.00
$3,639,000.00
Revenue This Year
$32.79
$126.00
Revenue Next Year
$4.47
$110.01
P/E Ratio
$8.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.03
$1.09
52 Week High
$7.73
$4.19

Technical Indicators

Market Signals
Indicator
OPRT
CBUS
Relative Strength Index (RSI) 51.06 32.69
Support Level $4.63 $1.35
Resistance Level $4.84 $1.71
Average True Range (ATR) 0.24 0.30
MACD 0.05 -0.13
Stochastic Oscillator 89.02 1.08

Price Performance

Historical Comparison
OPRT
CBUS

About OPRT Oportun Financial Corporation

Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: